CANSINO BIOLOGICS IN

6185
End-of-day quote. End-of-day quote  - 01/18
244.6HKD +4.44%
Prev.234.2000
Open232.8000
High244.6000
Low228.0000
Volume802 824
Latest news
16h ago
16h ago
18h ago
01/11
Chart CANSINO BIOLOGICS INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralBullish
Resistance249271271
Spread/Res.-1,8%-9,9%-9,9%
Spread/Supp.31%71%71%
Support187143143
Financials
Sales 2020 94,1 M 14,5 M 14,5 M
Net income 2020 -6,87 M -1,06 M -1,06 M
Net cash 2020 2 901 M 448 M 448 M
P/E ratio 2020 -8 148x
Yield 2020 -
Capitalization 69 528 M 10 713 M 10 732 M
EV / Sales 2020 708x
EV / Sales 2021 18,0x
Nbr of Employees 429
Free-Float 37,1%
Company
CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in...

>> Read more
Sector :
Biopharmaceuticals
Calendar :
2021-03-29 Earnings Release
Trading Rating :
Investor Rating : -

Income Statement Evolution
Consensus
Mean consensus BUY
Number of Analysts 6
Average target price 171,22 CNY
Last Close Price 204,75 CNY
Spread / Highest target 6,17%
Spread / Average Target -16,4%
Spread / Lowest Target -77,5%